444 related articles for article (PubMed ID: 30355263)
21. Variants of ZBTB7A (LRF) and its β-globin gene cluster binding motifs in sickle cell anemia.
Shaikho EM; Habara AH; Alsultan A; Al-Rubaish AM; Al-Muhanna F; Naserullah Z; Alsuliman A; Qutub HO; Patra PK; Sebastiani P; Baltrusaitis K; Farrell JJ; Jiang Z; Luo HY; Chui DH; Al-Ali AK; Steinberg MH
Blood Cells Mol Dis; 2016 Jul; 59():49-51. PubMed ID: 27282567
[No Abstract] [Full Text] [Related]
22. Gene Therapy as the New Frontier for Sickle Cell Disease.
Garg H; Tatiossian KJ; Peppel K; Kato GJ; Herzog E
Curr Med Chem; 2022; 29(3):453-466. PubMed ID: 34047257
[TBL] [Abstract][Full Text] [Related]
23. Cellular function reinstitution of offspring red blood cells cloned from the sickle cell disease patient blood post CRISPR genome editing.
Wen J; Tao W; Hao S; Zu Y
J Hematol Oncol; 2017 Jun; 10(1):119. PubMed ID: 28610635
[TBL] [Abstract][Full Text] [Related]
24. Structural basis for human ZBTB7A action at the fetal globin promoter.
Yang Y; Ren R; Ly LC; Horton JR; Li F; Quinlan KGR; Crossley M; Shi Y; Cheng X
Cell Rep; 2021 Sep; 36(13):109759. PubMed ID: 34592153
[TBL] [Abstract][Full Text] [Related]
25. CRISPR/Cas9 gene editing for curing sickle cell disease.
Park SH; Bao G
Transfus Apher Sci; 2021 Feb; 60(1):103060. PubMed ID: 33455878
[TBL] [Abstract][Full Text] [Related]
26. A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease.
Cai L; Bai H; Mahairaki V; Gao Y; He C; Wen Y; Jin YC; Wang Y; Pan RL; Qasba A; Ye Z; Cheng L
Stem Cells Transl Med; 2018 Jan; 7(1):87-97. PubMed ID: 29164808
[TBL] [Abstract][Full Text] [Related]
27. Diverse Approaches to Gene Therapy of Sickle Cell Disease.
White SL; Hart K; Kohn DB
Annu Rev Med; 2023 Jan; 74():473-487. PubMed ID: 36067800
[TBL] [Abstract][Full Text] [Related]
28. Genetic therapies for sickle cell disease.
Esrick EB; Bauer DE
Semin Hematol; 2018 Apr; 55(2):76-86. PubMed ID: 29958563
[TBL] [Abstract][Full Text] [Related]
29. Curative approaches for sickle cell disease: A review of allogeneic and autologous strategies.
Bauer DE; Brendel C; Fitzhugh CD
Blood Cells Mol Dis; 2017 Sep; 67():155-168. PubMed ID: 28893518
[TBL] [Abstract][Full Text] [Related]
30. Gene therapy for sickle cell disease: An update.
Demirci S; Uchida N; Tisdale JF
Cytotherapy; 2018 Jul; 20(7):899-910. PubMed ID: 29859773
[TBL] [Abstract][Full Text] [Related]
31. Genome Editing for Sickle Cell Disease: A Little BCL11A Goes a Long Way.
Hossain MA; Bungert J
Mol Ther; 2017 Mar; 25(3):561-562. PubMed ID: 28190778
[No Abstract] [Full Text] [Related]
32. Fetal haemoglobin induction in sickle cell disease.
Paikari A; Sheehan VA
Br J Haematol; 2018 Jan; 180(2):189-200. PubMed ID: 29143315
[TBL] [Abstract][Full Text] [Related]
33. Lineage-specific BCL11A knockdown circumvents toxicities and reverses sickle phenotype.
Brendel C; Guda S; Renella R; Bauer DE; Canver MC; Kim YJ; Heeney MM; Klatt D; Fogel J; Milsom MD; Orkin SH; Gregory RI; Williams DA
J Clin Invest; 2016 Oct; 126(10):3868-3878. PubMed ID: 27599293
[TBL] [Abstract][Full Text] [Related]
34. Wake-up Sleepy Gene: Reactivating Fetal Globin for β-Hemoglobinopathies.
Wienert B; Martyn GE; Funnell APW; Quinlan KGR; Crossley M
Trends Genet; 2018 Dec; 34(12):927-940. PubMed ID: 30287096
[TBL] [Abstract][Full Text] [Related]
35. Sickle Cell Disease: From Genetics to Curative Approaches.
Hardouin G; Magrin E; Corsia A; Cavazzana M; Miccio A; Semeraro M
Annu Rev Genomics Hum Genet; 2023 Aug; 24():255-275. PubMed ID: 37624668
[TBL] [Abstract][Full Text] [Related]
36. Gene editing for sickle cell disease and transfusion dependent thalassemias- A cure within reach.
Eckrich MJ; Frangoul H
Semin Hematol; 2023 Jan; 60(1):3-9. PubMed ID: 37080708
[TBL] [Abstract][Full Text] [Related]
37. Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison Study.
Urbinati F; Campo Fernandez B; Masiuk KE; Poletti V; Hollis RP; Koziol C; Kaufman ML; Brown D; Mavilio F; Kohn DB
Hum Gene Ther; 2018 Oct; 29(10):1153-1166. PubMed ID: 30198339
[TBL] [Abstract][Full Text] [Related]
38. Investigational curative gene therapy approaches to sickle cell disease.
Williams DA; Esrick E
Blood Adv; 2021 Dec; 5(23):5452. PubMed ID: 34905048
[TBL] [Abstract][Full Text] [Related]
39. CRISPR/Cas9 for Sickle Cell Disease: Applications, Future Possibilities, and Challenges.
Demirci S; Leonard A; Haro-Mora JJ; Uchida N; Tisdale JF
Adv Exp Med Biol; 2019; 1144():37-52. PubMed ID: 30715679
[TBL] [Abstract][Full Text] [Related]
40. Gene Addition Strategies for β-Thalassemia and Sickle Cell Anemia.
Dong AC; Rivella S
Adv Exp Med Biol; 2017; 1013():155-176. PubMed ID: 29127680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
